Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparan sulfate (HS) is a complex, highly sulfated linear polysaccharide found on the surface of almost all animal cells and within the extracellular matrix, typically as part of heparan sulfate proteoglycans (HSPGs) (Source: UniProt). In the context of human metapneumovirus (hMPV) infection, HS serves as a critical initial attachment factor, where the viral glycoproteins—specifically the G and F proteins—bind to the negatively charged sulfate groups of the HS chains (Source: Journal of Virology, DOI: 10.1128/JVI.78.10.5003-5011.2004). This interaction facilitates the concentration of viral particles on the host cell membrane, promoting subsequent fusion and entry into the cytoplasm (Source: PubMed: 15141017). Because this attachment step is essential for efficient infection, HS and its biosynthetic pathways are significant targets for antiviral drug development. Therapeutic agents such as heparin, suramin, and other HS mimetics function by competitively binding to the virus, thereby blocking its ability to dock with the host cell (Source: PubMed: 17041217). However, the use of such polyanionic compounds faces challenges, including potential systemic anticoagulant effects and interference with endogenous growth factor signaling (Source: StatPearls). Beyond hMPV, HS is involved in the entry of various other pathogens, making it a target for broad-spectrum antiviral research. Its role in cell signaling and adhesion also links it to cancer and inflammatory diseases, where HS-modifying enzymes are often dysregulated.
Competitive inhibition of viral attachment; the drug acts as a decoy, binding to the viral glycoproteins (G or F) and preventing their interaction with host cell-surface heparan sulfate proteoglycans (Source: PubMed: 15141017).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparan sulfate (HS) (HS).